Steris (STE) Long-Term Debt Issuances (2020 - 2021)

Steris (STE) recorded quarterly Long-Term Debt Issuances of $700.0 million in Q3 2021, up 7.69% quarter-over-quarter from $650.0 million in Q2 2021.

Steris (STE) Long-Term Debt Issuances (2020 - 2021) Analysis & Trends

Steris' Long-Term Debt Issuances history runs 2 years deep, the most recent figure standing at $700.0 million for Q3 2021.

In Q3 2021, Long-Term Debt Issuances changed N/A year-over-year to $700.0 million; the TTM figure through Jun 2022 stood at $700.0 million (up 7.69% YoY), while the FY2022 annual figure was $1.4 billion, changed N/A from the prior year.
Long-Term Debt Issuances was $700.0 million for Q3 2021 at Steris, up from $650.0 million in the prior quarter.
In the past five years, Long-Term Debt Issuances ranged from a high of $700.0 million in Q3 2021 to a low of -$550.0 million in Q1 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Debt Issuances (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	19.86 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	-
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	-
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	-
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	-
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	11.71 Mn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	1.15 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	-
10	Zimmer Biomet Holdings	17.18 Bn	16.77 Bn	1.51 Bn	-

Download Data